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sible antagonist pairings within 2 sets of 10 antagonist strains (5 x lOS CFU of each strain per ml) resulted in 16 of 90 pairs controlling disease better than predicted based on averaging the performance of the individual strains making up the pair (P < 0.10). Successful pairs reduced disease by -70% versus controls, a level of control comparable to that obtained with 100 times the inoculum dose of a single antagonist strain. Neither strain genus nor soil of origin were useful in predicting successful antagonist pairs. Factors potentially influencing dose-response relationships and the effectiveness of antagonist pairs in controlling disease are discussed.
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To succeed in suppressing Fusarium dry rot, antagonists would only need to prevent pathogen invasion during this relatively short period of time. Additionally, storage conditions for potato tubers (relative humidities generally greater than 80% and temperatures ranging from 5 to 15°C) are favorable for growth of many microbial agents. Although yeast strains are rarely effective in controlling this disease (35) , 18 bacterial strains have been identified that substantially reduce and sometimes eliminate potato dry rot development incited by G. pulicaris (36) .
The relationship between antagonist inoculum dose and the level of disease control realized remains to be determined for any of the antagonists active against dry rot. Such information represents a critical step in accurately evaluating the economics of producing a biocontrol product and predicting the level of control realized when using decreasing numbers of antagonist cells against Fusarium dry rot. Raaijmakers et al. (31) demonstrated the existence of a threshold level of antagonist inoculum below which large changes in disease control resulted from small decreases in antagonist dose. n is not known whether similar thresholds exist for log-dose, logdisease response curves of dry rot antagonists.
The feasibility of producing an economical biocontrol product would be improved further if techniques were devised that enabled significantly fewer antagonist cells to be utilized without substantially reducing the level of disease control realized. One approach that may accomplish this goal would be to evaluate pairs of microbial strains, each at a dose considerably less than employed when used singly, to identify microbial pairs that give control equivalent to single antagonist strains used at considerably higher cell concentrations. Multiple strain mixtures of microbial agents have been employed with some success against plant pathogens in previous studies (11,12,17,18,22,24--26,29,39,43) . These studies have concentrated on determining whether mixtures of antagonists control disease, especially when individual strains of a mixture provide inadequate disease control.
Although multiple strain mixtures are logically defendable based on the fact that they more closely mimic the microbial environ- (Table 1) , or selected strains from this group, were used. These strains have been demonstrated ment present on plant tissues, the commercial development of a multiple-strain mixture product would likely require the development of separate production, stabilization, and formulation protocols for each strain. Additionally, strains of a mixture would likely have to be produced and registered separately. Thus, economic incentive favors minimizing the number of strains in a mixture. The current study concentrates on identifying two-strain mixtures of antagonists that are effective at low dosage in controlling disease. The likelihood of discovering pairs of antagonists that would effectively biologically control Fusarium dry rot is considerable, because all microbial antagonists effective against Fusarium dry rot produce antibiotic compounds, and many strains differ substantially in the profiles of compounds produced (3). Complimentary antibiotic production by strains making up an antagonist pair could result in increased effectiveness against individual strains of G. pulicaris and a broader spectrum of postharvest pathogens of potatoes.
MATERIALS AND METHODS
The purpose of the current study was to determine the relationship between the dose of 18 potato dry rot antagonists and the level of disease control realized. For selected strains of antagonists, small incremental changes in antagonist concentration were used to further clarify the dose-response relationship. An additional purpose of this study was to evaluate a large number of antagonist pairings using a reduced inoculum dose with the objective of discovering antagonist pairs that control disease to an extent comparable to that realized with higher numbers of cells of individual antagonist strains. Antagonist pairs that controlled Fusarium dry rot to a greater level than predicted were characterized by the taxonomic grouping and soil of origin of the strains making up the pair to determine whether such characteristics could be useful in predicting additional successful antagonist pairings. previously to be effective in suppression of Fusarium dry rot of potato tubers (36) . All bacterial strains were originally isolated from gamma irradiation-sterilized field soil samples that had been enriched with potato tuber periderm, inoculated with soils obtained from potato-growing regions in Wisconsin, and found to be suppressive to Fusarium dry rot disease development. Potato (Solanum tuberosum L. 'Russet Burbank') tubers, obtained from commercial suppliers of seed potatoes, were utilized in all trials. Tubers were stored at 8°C. Twenty-four hours before use, tubers were gently washed in deionized water and allowed to warm to 20°C. A suspension of macroconidia of G. pulicaris R-6380 (deposited at the Fusarium Research Center, The Pennsylvania State University, University Park) was produced as described elsewhere (9) , except that conidia were suspended in 4°C P0 4 buffer (0.004% phosphate buffer [pH 7.2] with 0.019% MgCI 2 ; Aid-Pack USA, Gloucester, MA). Bacterial strains were taken from 10% glycerol, -80°C freezer cultures and streaked onto lis-strength tryptic soy broth agar (TSBA/5; Difco Laboratories, Detroit) 2 to 3 days before use. Cultures were restreaked onto TSBA/5 and incubated at 28°C. Just before use, slightly turbid suspensions of antagonist cells in 4°C P0 4 buffer were prepared from 18-h-old cultures. Cells grown on solid medium, rather than liquid medium, were utilized because agar-produced cells more consistently maintained CFU counts per milliliter when suspended in liquid and, therefore, could be more accurately adjusted to specific concentrations. Before tuber inoculation, conidial and bacterial suspensions were mixed (1:1) with final concentrations of 5 x lOS conidia per rnl and 1 x 10 8 CFU/ml, respectively, unless otherwise noted.
Tubers were inoculated, incubated, harvested, and evaluated for disease symptoms according to methods described by Schisler and Slininger (36) . Briefly, tubers were uniformly wounded at four sites spaced at equal distances around the circumference of tubers with a blunted steel nail. Wounds were inoculated with 5 III of a mixed suspension of G. pulicaris and a bacterial antagonist. Controls consisted of wounds inoculated with P0 4 buffer or suspensions of macroconidia (5 x lOS conidia per ml). Tubers were harvested after 3 weeks of incubation in trays at 15°C. The extent of disease was evaluated by quartering the tubers longitudinally through each of the four wounds and measuring from a wound site the total depth and width of exposed necrotic tissue. In all trials, there was a total of four replicate wounds per treatment, except for 16 replicate wounds for G. pulicaris only controls. The four replicate wounds per treatment occurred once on each of four different potato tubers. Thus, a single tuber contained one replicate wound of each of four treatments. Values from experiments were log-transformed to normalize data when required before statistical analysis. All experiments were conducted twice unless otherwise noted. Data from repeated, iden- gorized by genus and soil of origin as were strains from pairs that did not achieve enhanced levels of disease protection. Chi-square analysis was used to determine whether antagonist pair genus and soil of origin were useful predictors of antagonist pair performance against dry rot.
RESULTS
Y Means for bacterial antagonists are pooled results from four replicate wounds for each of the three cell concentrations used (10 6 , 10 7 , and 10 8 CFU/rnl). The control value is the mean of 16 replicate wounds. Significant experiment by antagonist interaction precluded pooling data from experiments I and 2. ZWithin a column, values followed by one or two asterisks are significantly different from the control based on Fisher's protected LSD (P < 0.05 and 0.01, respectively). Analysis of variance and mean comparisons were performed on log-transformed data. The values shown represent back-transformed data. Control of G. pulicaris R-6380 with three concentrations of 18 bacterial antagonists. ANOVA revealed that although concentration effects did not significantly interact with antagonist strain effects in either experiment (P < 0.61 and 0.08 for experiments 1 and 2, respectively), both concentration and antagonist effects significantly interacted with experiment (concentration by experiment, P < 0.001; antagonist by experiment, P < 0.04). Thus, overall concentration and antagonist effects were calculated separately for experiments 1 and 2.
In both experiments, an antagonist dose of I x 10 8 CFU/ml was very effective in controlling disease development incited by G. plllicaris R-6380, with a 76% reduction in disease compared to controls for both experiments ( Table 2 ). In experiment 2, the lowest antagonist concentration assayed (l x 10 6 CFU/ml) was more effective in controlling disease (66% reduction versus G. plllicaris control) than was found in experiment 1 (38% reduction versus G. pulicaris). Disease control significantly differed depending on antagonist dose in experiment 1, whereas a dose of 10 7 or 10 8 CFU/ ml did not differ in effect on disease control in experiment 2.
Depending on the experiment, individual antagonists sometimes differed in their overall effect, but generally, antagonists significantly decreased the level of disease incited by G. pulicaris (Table 3) . In experiment 1, 15 of 18 antagonists significantly decreased disease compared to the control (P < 0.01), whereas 16 of 18 antagonists controlled disease at the P < 0.05 level. All 18 antagonists decreased disease at the P < 0.01 level in experiment 2 ( Table 3 ).
The percent reduction in disease when using antagonists ranged from 40 to 77% in experiment 1 and 63 to 78% in experiment 2.
tical experiments were pooled if treatment by experiment interactions were not significant.
Control of G. pulicaris R-6380 with three concentrations of 18 bacterial antagonists.
Suspensions of all 18 bacterial strains were prepared and adjusted to an absorbance of 0.17 at 620 nm (-2 x 10 8 CFU/ml). A portion of each bacterial suspension was diluted 1/10 and 11100. A conidial suspension of G. pulicaris R-6380 was prepared with a concentration of 1 x 10 6 conidia per mi. Equal aliquots of bacterial and conidial suspensions were combined and used to inoculate tubers (final concentration of each microbe was one-half the prepared concentration). A complete factorial design with 3 levels of antagonist concentration and 18 levels of antagonist was employed. Statistical analysis was performed by SAS, version 6.07 (SAS Institute, Cary, NC). Data were log-transformed before analysis of variance (ANOVA) of the 3 x 18 factorial data set. Overall concentration and antagonist effects were determined after ANOVA showed that interaction between these factors was not significant. G. pulicaris controls were restored to the database, and the differences between concentration levels or bacterial antagonists and the control were determined by one-way ANOVA. Means were separated by Fisher's protected LSD test. The values reported represent back-transformed data.
Dose-response of dry rot to 11 concentrations of four bacterial antagonists. Results from assays with three concentrations of each bacterial antagonist indicated that selecting several antagonists and evaluating an increased number of dosages of each would permit a more concise relationship between antagonist dose and disease control to be formulated. Bacterial antagonists S22:T:04, Sl1:T:07, Sl1:P:08, and S09:Y:08 were selected for detailed study due to their high commercial development ranking (i.e., they possess favorable growth kinetics and biocontrol efficacy when produced in liquid culture media [40] ). For each of the antagonists, cell suspensions in P0 4 buffer were prepared as described above, and absorbencies were set at 0.170 at 620 nm (-2 X 10 8 CFU/ml). Each suspension was diluted serially by one-half 10 times, such that 11 cell suspensions ranging from 2 x 10 8 to 2 X 10 5 CFU/ml were prepared. Each antagonist cell suspension was combined I: I with a 1 x 10 6 conidia per ml suspension of G. pulicaris in P0 4 buffer. Bacterial cell and conidial mixtures were used to inoculate wounds in tubers (final suspension concentrations of 1 x 10 8 to 1 X 10 5 CFU/ml for bacterial cells and 5 x 10 5 conidia per ml for G. plllicaris). Disease data (dependent variable) resulting from assays and antagonist concentration (independent variable) were IOgIO transformed before dose-response models were constructed for each antagonist. Values for R 2 were calculated based on treatment means. Dry rot control with pairs of antagonists. For the first set of replicated experiments, 10 antagonist strains were selected at random from the 18 available strains and paired in all possible combinations for assay against G. plllicaris (45 different treatment pairs). Bacterial and conidial suspensions were prepared separately as described earlier and combined to form suspensions containing cells of each of the antagonists making up a pair (5 x 10 5 CFU of each per ml) and G. pulicaris (5 x 10 5 conidia per ml). Suspensions containing only one bacterial strain and conidia of G. pulicaris also were prepared (final concentration of 1 x 10 6 CFU/ml and 5 x 10 5 conidia per mI, respectively). Wounded tubers were inoculated with mixed microbial suspensions. A second set of 10 antagonists composed of the 8 untested strains and 2 strains selected at random from the previously assayed group were paired in all possible combinations and assayed against G. pulicaris. In total, 90 antagonist pairs and 18 individual strains were evaluated. Disease was assayed after 3 weeks of incubation as described earlier. ANOVA was performed on contrasts of the predicted versus actual level of disease that occurred when a specific antagonist pair was used. The predicted level of disease was derived by averaging the level of disease that resulted when each antagonist of a pair was assayed individually against G. plllicaris. Individual antagonists of pairs that controlled disease better than predicted (P < 0.10) were cate-Dose-response of dry rot to 11 concentrations of four bacterial antagonists. ANOVA detennined that for only one of the four antagonists (S22:T:04) experiment by concentration interaction was significant (P < 0.03). A plot of data obtained in experiments with S22:T:04 revealed that data from one concentration level accounted for the significance of the interaction. Data from both experiments, therefore, was pooled for each of the four antagonists, and doseresponse curves were detennined. Linear models provided the best fit of the relationship between log antagonist dose and log diseased tissue for each antagonist over the concentrations tested (Fig.  lA through D) .
Linear regression of the dose-response data of S22:T:04, Sl1:T:07, SI1:P:08, and S09:Y:08 was significant at P < 0.01 for S22:T:04 and at P < 0.001 for the other three antagonists. Where y is defined as IOglO diseased potato tissue (millimeters) and x is defined as IOglO bacterial antagonist concentration (CFU per milliliter), the respective dose-response models for S22:T:04, SI1:T:07, Sl1:P:08, (Fig. 1) . A dose of 0 antagonist (corresponding log disease value of 1.49) was not included in the models. Dry rot control with pairs of antagonists. Because ANOVA did not reveal significant antagonist pair by experiment interactions for either set of antagonists, data from each replicated experiment were pooled. A total of 16 of 90 pairs of antagonists controlled dry rot better than predicted from the level of control obtained by each strain making up the pair (Table 4) . Coinoculation with strains P22:Y:05 and S22:T:04, for instance, resulted in only 8.7 mm of diseased tissue, whereas the same total number of cells of each strain inoculated individually resulted in 20.9 and 18.8 mm of diseased tissue, respectively. The level of disease control realized when coinoculating with these strains was significantly less (P < 0.01) than the predicted result (19.8 mm) and 71% less than the G. pulicaris control (Fig. 2) . Effective antagonist pairs controlled disease 40 to 69% better than predicted based on the performance of the strains making up the pairs and reduced disease by 54 to 85% compared to G. pulicaris controls (Table 4) . On average, effective pairs decreased disease by -50% compared to the predicted level and by -70% compared to G. pulicaris controls ( Table 5) .
The 18 bacterial antagonists used in this study were isolated from three different soils (S09, SI1, and S22). For antagonist pairs isolated from the same soil, 7 of 33 pairs controlled disease better than predicted, whereas 9 of 57 pairs consisting of strains isolated from different soils controlled disease better in dual versus single inoculation. Chi-square analysis (P < 0.05) detennined that these ratios did not differ, demonstrating that antagonist pairs consisting of strains with the same soil of origin did not have an increased likelihood of enhanced disease control capability. Seven of forty-four pairs composed of coinoculants of the same genus controlled disease better than predicted, whereas nine of forty-six pairs composed of coinoculants of differing genera controlled disease better than predicted. These ratios do not differ according to chi-square analysis (P < 0.05). Pairs of antagonists of the same genus, therefore, were no more likely to exhibit enhanced disease control than were pairs made up of antagonists of differing genera. v Bacterial antagonists were assayed at a total concentration of I x 10 6 CFU/mI, with each pair member at 5 x Ias CFU/mI. wEach antagonist set was composed of 10 different antagonists, except for 2 antagonists that were used in both sets. x Contrast of predicted versus actual disease was performed on log-transformed data and was significant at the P value listed. Values for each antagonist set represent pooled results from two experiments and were backtransformed. y The predicted level of control for an antagonist pair was calculated by averaging the control achieved when individually assaying each strain of the pair at I x 10 6 CFU/mI. In experiments on dose-response with all 18 bacterial antagonists of Fusarium dry rot, doses of I x 10 8 CFU/ml proved effective in controlling the disease, whereas less, but still significant, control was demonstrated at cell concentrations of 1 x 10 7 and 1 x 10 6 CFU/ml. With rare exceptions, all 18 antagonists were effective in controlling dry rot, confirming results from a previous study (36) . In a more detailed study of the dose-response relationship with four selected bacterial antagonists, the dose-response relationship was well described by a log-linear model (log disease = m(log dose) + b) for all of the antagonists over the 11 step range of concentrations between 1 x 108 and 1 x 10 5 CFU/ml. Although our data fit a log-linear relationship of dose-response with antagonist concentrations in the 10 5 to 108 CFU/ml range tested, most dose-response models predict that at fixed pathogen dose increasing concentrations of antagonist cells will eventually provide a diminishing level of disease control, asymptotically reaching a point where no further disease control is achieved with increasing antagonist dose (20, 27) . This diminishing return in disease control with increasing antagonist dose likely results from a decreasing amount of pathogen inactivation occurring per unit of biocontrol agent at high biocontrol agent densities (20, 27) . In repeated experiments (D. A. Schisler, P. 1. Slininger, and R. 1. Bothast, unpublished data) conducted separately from those reported here, we found that a dose of 10 9 CFU/ml (average result of all 18 antagonists) resulted in disease reduction of70% compared to controls. Because a dose of 108 CFU/ml resulted in a 76% reduction in disease in the current study, it is possible that a dose of 108 CFU/ml provides close to the maximum level of control achiev- WBacterial antagonist assayed at a concentration of I x 10' CFU/mI. x Two of ninety (2%) antagonist pairs performed worse than predicted in controlling disease. These pairs had 175% more disease than predicted but decreased disease versus R-6380 by 33%. y The predicted level of control for a pair of antagonists was calculated by averaging the control achieved when individually assaying each strain of an antagonist pair. Z For each antagonist set, values represent pooled results from two experiments.
able under the conditions of pathogen dose and environmental parameters used. Studies with small incremental concentration increases in antagonist dose above the level of 10 8 CFU/ml used in this study would be needed to determine definitively where the log-dose response curve becomes nonlinear, with progressively less reduction in disease per unit of log-antagonist concentration.
Working with Fusarium wilt of radish, Raaijmakers et al. (31) found a sharp inflection in an antagonist dose disease response plot when bacterial populations on roots dropped below a level that corresponded with an asymptotic, maximal level of disease suppression. Our results may be considered similar in concept if a dose of -1 x 10 8 CFU/ml provides near maximal disease suppression. It is likely that antagonist doses much lower than those used in the studies with four antagonists would have had not have decreased in disease because the level of disease with no antagonist (i.e., the Gibberella pulicaris R-6380 control, which had a 10glO millimeter of diseased tissue value of 1.49) was approximately equivalent to the level of disease seen with our lowest inoculum concentration for each of the four antagonists tested. Thus, our logarithmic dose-response function must become nonlinear and parallel the x-axis at antagonist doses only slightly less than 1 x 10 5 CFU/ml. As graphically demonstrated in our box and whisker plots of diseased tissue versus antagonist dose (Fig. IA through D) , the level of variability frequently encountered in experimentation with biocontrol systems confounds the direct application of results to dose-response theory. Variation in the level of disease incited by G. pulicaris may be explained partially by differences in individual tuber physiology. Interestingly, in a recent study, Pierson et al. (30) determined that phenazine antibiotic production by Pseudomonas aureofaciens 30-84 is regulated by cell density, with maximal gene expression occurring at high cell densities. Should similarly regulated antibiotic production genes be present in strains utilized in the current study, the highly variable levels of biological control realized with slight changes in antagonist dose may be due, in part, to whether antagonist cells inoculated into wounds subsequently reached population densities adequate to induce genes involved in antibiotic production or other biocontrol functions.
In addition to their utility in driving biocontrol research approaches and interpretations, dose-response models will undoubtedly be of use in developing rate recommendations for product labels and calculating cost analysis for product production. However, even with dose-response models well characterized for various antagonist and pathogen inoculum levels in laboratory settings, direct application of these models for developing recommended label doses is problematic, because pathogen concentration and factors influencing interaction between antagonist and pathogen inoculum will differ greatly at individual sites of product deployment. Pathogen dose and factors influencing the level of pathogen inactivation occurring per unit of biocontrol agent is predicted to radically change resultant dose-response curves (20, 27) . Additionally, although the microbial cultivation environment (32, 33, 40) and formulation (16, 34, 41) can influence microbial function, the influence of these factors on antagonist dose-response has not been studied. Final dose recommendations for biocontrol products, therefore, will be most accurately determined after the composition of large-scale fermentation media and product formulations for commercial use have been finalized.
Mixtures of microbial antagonists have been used successfully to increase the level of biological control above that achieved with individual strains of the mixture (11, 12, 17, 18, 22, 24, 25, 26, 29, 39, 43) . In our studies, bacterial antagonists were combined at 11100 the concentration of an effective dose of the individual strains making up the pair. Sixteen pairs of antagonists controlled dry rot development better than predicted based on the performance of the individual strains making up the pairs.
There are several plausible explanations for the synergistic disease control seen with some pairs of antagonists. Although factors such as soil of origin or taxonomic grouping of each isolate of an 182 PHYTOPATHOLOGY antagonist pair were not useful in predicting whether the pair would exhibit superior dry rot control, this could be due to the categorizations being too general to identify microbial traits that may act together to enhance disease control. Coexistence and interaction of microbes is the norm in nature. When niche overlap was minimal, different epiphytic bacterial strains exhibited higher levels of coexistence than those with similar niche preferences on bean leaves (46) . A portion of this successful coexistence was attributed to compatible strains possessing differing carbon substrate utilization profiles. Janisiewicz (18) demonstrated that combining two antagonists on the basis of niche differentiation increased the chance that the antagonist pair would display improved control of Penicillium expansum on apple fruit. Diverse niches also are likely to be found in potato wounds, which would possibly result in G. pulicaris being exposed to higher total bacterial populations and a wider range of nutrient competition when challenged by coexisting mixtures of microbial strains than would be the case with a single inoculant. Determining substrate utilization profiles of strains of antagonist pairs that are successful or unsuccessful in controlling disease would provide further clues as to the nature of the disease control success of some antagonist pairs, as would evaluation of the colonization characteristics of successful and unsuccessful pairs of potato dry rot antagonists.
The success of some antagonist pairs also may be attributable to individual strains of a pair possessing complementary modes of action. Numerous modes of action have been postulated and demonstrated for antagonists effective in controlling postharvest diseases, including nutrient competition, antibiotic production, enzymes that act on fungal cell wall components, such as chitinases and~ 1,3 glucanase, and induced host resistance (2, 3, 10, 44, 45) . Results of a study by Lemanceau et al. (26) suggested that antibiotic production by a bacterial antagonist resulted in a pathogenic strain of F. O),:ysporum being more sensitive to glucose competition from a nonpathogenic F. O."'(ysporum. Certainly the wide array of antibiotic compounds produced by the 18 antagonist strains considered in this study (3) support the possibility that complimentary antibiotic production accounts for the biocontrol success of some pairs.
A biocontrol product composed of a mixture of antagonists does have a potential drawback: producing and registering such a product could be more costly in the investment of materials, equipment, and production time than a product composed of a single antagonist. However, in this study, successful antagonist pairs decreased Fusarium dry rot by an average of -70%, with some pairs decreasing disease by as much as 85%, whereas individual strains utilized at 100 times the cell concentration decreased disease by an average of 75% compared to controls. Thus, over time the savings from achieving an effective dose with 11100 the number of antagonist cells may more than offset the added expense of producing a biocontrol product composed of two microbial strains. As with studies concerned with clarifying dose-response curves with these antagonists, final judgment on the economics and feasibility of producing a biocontrol product composed of a mixture of two antagonist strains must await the results of studies to determine the impact of liquid culture nutritional environment and cell formulation on the biocontrol activity of antagonists applied as individuals and in pairs.
